Fundz

Meiragtx Announces Financing Agreement With Perceptive Advisors For Up To $100 Million Secured By Manufacturing Facilities

PUBLIC · MGTXAug 03, 2022

Round Type

Debt Financing

New YorkBiotechnologyHealth CareGeneticsTherapeutics

Description

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, today announced a term loan agreement with affiliates of Perceptive Advisors for up to $100 million, including $75 million upon closing.

Quick answer

MeiraGTx Holdings plc raised an undisclosed amount in a Debt Financing round, dated August 3, 2022. MeiraGTx Holdings plc is based in New York, New York, United States.

How much did MeiraGTx Holdings plc raise?
MeiraGTx Holdings plc raised an undisclosed amount in a Debt Financing round on August 3, 2022.
What does MeiraGTx Holdings plc do?
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs.
Where is MeiraGTx Holdings plc based and how big is it?
MeiraGTx Holdings plc is based in New York, New York, United States. Fundz records about 51 employees.
Who are the decision-makers at MeiraGTx Holdings plc?
Fundz holds 2 contacts at MeiraGTx Holdings plc, including the Senior Human Resources Business Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as MeiraGTx Holdings plc that raised within 45 days of this round, from Fundz verified event records.

  • Photys Therapeutics raised $75M (Series A) on September 8, 2022.
  • Inherent Biosciences raised an undisclosed amount (Series A) on September 7, 2022.
  • Inherent Biosciences raised $1.5M (Seed) on August 19, 2022.
  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • Carver raised an undisclosed amount (Seed) on September 15, 2022.
  • Novome raised an undisclosed amount (Funding Round) on September 15, 2022.

Who to call at MeiraGTx Holdings plc, and when

A new round usually means MeiraGTx Holdings plc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MeiraGTx Holdings plc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MeiraGTx Holdings plc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MeiraGTx Holdings plc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MeiraGTx Holdings plc

Location

States 450 East 29Th Street

New York, New York, United States

About

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, and a transformative gene regulation platform technology that allows precise, dose-responsive control of gene expression by oral small molecules with dynamic range that can exceed 5000-fold. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring, and developing technologies that give depth across both product candidates and indications. MeiraGTx’s initial focus is on three distinct areas of unmet medical need: ocular diseases, including both inherited retinal diseases as well as large degenerative ocular diseases, neurodegenerative diseases, and severe forms of xerostomia. Though initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx plans to expand its focus to develop additional gene therapy treatments for patients suffering from a range of serious diseases. For more information, please visit www.meiragtx.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MeiraGTx Holdings plc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSarah J., Senior Human Resources Business Partner hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MeiraGTx Holdings plc's next move

See what Strategic adds

MeiraGTx Holdings plc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.